4//SEC Filing
Shaw Christi 4
Accession 0000059478-19-000183
CIK 0000059478other
Filed
May 6, 8:00 PM ET
Accepted
May 7, 2:18 PM ET
Size
7.0 KB
Accession
0000059478-19-000183
Insider Transaction Report
Form 4
Shaw Christi
SVP and Pres., Lilly Bio-Meds
Transactions
- Sale
Common Stock
2019-05-03$117.99/sh−500$58,995→ 0 total - Sale
Common Stock
2019-05-03$117.08/sh−7,077$828,575→ 500 total
Footnotes (3)
- [F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019.
- [F2]This transaction was executed in multiple trades at prices ranging from $116.68 to $117.46. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $117.82 to $118.15. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
LILLY ELI & CO
CIK 0000059478
Entity typeother
Related Parties
1- filerCIK 0001702473
Filing Metadata
- Form type
- 4
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 2:18 PM ET
- Size
- 7.0 KB